Skip to main content

Logo
  • Live News iconLive News
  • Smart Screener iconSmart Screener
  • Trade Opportunities iconTrade Opportunities
  • Alpha Watch iconAlpha Watch
  • Catalyst iconCatalyst
Skip to main content
Stock Ask Logo
Hi, Guest User

Log in or create an account to get full access

Open an Account (opens in a new window)

TOOLS

Live News
Smart Screener
Trade Opportunities
Alpha Watch
Catalyst

StockkASK powered by Indira Securities

Aakaar Medical Technologies Ltd (AAKAAR) Share Price & Fundamentals

Company Overview

Founded Year

2013

Listed Year

2025

Headquarter

Mumbai, India

MD/CEO

Dilip Ramesh Meswani

Website

https://www.aakaarmedical.in

Company Facts

What we do

Aakaar Medical Technologies Ltd specializes in medical aesthetics, supplying cosmetic products and devices predominantly to dermatologists and aesthetic physicians in India.

Founded in

2,013

Market share

Growing medical aesthetics company with rising revenues and expanding product portfolio in India.

Problem solved

Provides advanced aesthetic devices and products enabling physicians to offer innovative cosmetic treatments to end consumers.

Top clients or who we serve

B2B focus servicing dermatologists, plastic surgeons, and aesthetic physicians across India.

Key management

Dilip Ramesh Meswani (Founder & Managing Director), Dr. Rahul B. Sawakhande (CEO & Director)

Our journey and innovations

From inception in 2013, launched multiple own and imported pigment and aesthetic brands, expanded product range significantly by 2024.

Where we operate

Primarily India with imported products from Korea, Spain, Italy, and Austria.

Top products or what we offer

Own brands like Tubelite, Balback, Lytec, Etrelume, Swyada, Exoluxe; imported aesthetic devices and consumables.

Top brands

Tubelite, Balback, Lytec, Etrelume, Swyada, Exoluxe, DRS1512, Eoluxe—all key revenue drivers with growing market presence.

Raw materials needed

Cosmetic ingredients and electronic components for medical aesthetic devices sourced domestically and internationally.

Raw materials supplier

Suppliers from Korea, Spain, Italy, Austria; domestic manufacturers for own brands.

Recurring vs cyclical contribution

Primarily B2B product sales; revenue growth driven by expanding aesthetic products segment with recurring physician demand.

Our industry position

Emerging leader in India’s medical aesthetics sector with rapid revenue and profit growth over recent years.

Financial highlights

Revenue Rs 61.58 Cr (FY 24-25), Profit After Tax Rs 6.04 Cr; 33.5% revenue growth and 197% profit growth year-on-year.

Geographical revenue split

Revenue predominantly from India; distribution of imported brands involves multiple foreign countries.

Order book

-

Whats driving growth

Strong domestic demand for aesthetic solutions, product innovation, and expansion of own brand portfolio.

Our future plans

IPO planned to raise capital for working capital and general corporate purposes; expanding product pipeline.

Our green promise

-

Our people and values

Leadership with extensive industry experience fostering innovation and growth; compliance with workplace and ESG norms.

Key challenges ahead

Market competition, regulatory approvals, and dependency on import channels pose challenges.

Interesting facts

Transformed from private to public company; boasts diversified product brands launched between 2016-2024.

Risks and strategy

Mitigating import risks by strengthening own brands; maintaining regulatory compliance; pursuing B2B client relationships.

Market Footprint

Top Clients

Top Clients

B2B focus servicing dermatologists, plastic surgeons, and aesthetic physicians across India.

Top Products

Top Products

Own brands like Tubelite, Balback, Lytec, Etrelume, Swyada, Exoluxe; imported aesthetic devices and consumables.

Price Movement & Share Holding

Today's High/Low

7171

52 Week High/Low

46105
Past Returns

1 week

7.62%

1 month

4.4%

3 month

2.87%

1 year

-16.73%

3 year

-1.82%

5 year

-1.82%

Share Holding

Promoters

67.05%

FII

0%

DII

10.13%

Retail

18.52%

Others

4.3%

Company Overview

Founded Year

2013

Listed Year

2025

Headquarter

Mumbai, India

MD/CEO

Dilip Ramesh Meswani (Founder & Managing Director)

Website

https://www.aakaarmedical.in

Price Movement & Share Holding

Today's High/Low

7171

52 Week High/Low

46105

Past Returns

1 week

7.62%

1 month

4.4%

3 month

2.87%

1 year

-16.73%

3 year

-1.82%

5 year

-1.82%

Share Holding

Promoters

67.05%

FII

0%

DII

10.13%

Retail

18.52%

Others

4.3%

Company Facts

What we do

Aakaar Medical Technologies Ltd specializes in medical aesthetics, supplying cosmetic products and devices predominantly to dermatologists and aesthetic physicians in India.

Founded in

2013

Market share

Growing medical aesthetics company with rising revenues and expanding product portfolio in India.

Problem solved

Provides advanced aesthetic devices and products enabling physicians to offer innovative cosmetic treatments to end consumers.

Top clients or who we serve

B2B focus servicing dermatologists, plastic surgeons, and aesthetic physicians across India.

Key management

Dilip Ramesh Meswani (Founder & Managing Director), Dr. Rahul B. Sawakhande (CEO & Director)

Our journey and innovations

From inception in 2013, launched multiple own and imported pigment and aesthetic brands, expanded product range significantly by 2024.

Where we operate

Primarily India with imported products from Korea, Spain, Italy, and Austria.

Top products or what we offer

Own brands like Tubelite, Balback, Lytec, Etrelume, Swyada, Exoluxe; imported aesthetic devices and consumables.

Top brands

Tubelite, Balback, Lytec, Etrelume, Swyada, Exoluxe, DRS1512, Eoluxe—all key revenue drivers with growing market presence.

Raw materials needed

Cosmetic ingredients and electronic components for medical aesthetic devices sourced domestically and internationally.

Raw materials supplier

Suppliers from Korea, Spain, Italy, Austria; domestic manufacturers for own brands.

Recurring vs cyclical contribution

Primarily B2B product sales; revenue growth driven by expanding aesthetic products segment with recurring physician demand.

Our industry position

Emerging leader in India’s medical aesthetics sector with rapid revenue and profit growth over recent years.

Financial highlights

Revenue Rs 61.58 Cr (FY 24-25), Profit After Tax Rs 6.04 Cr; 33.5% revenue growth and 197% profit growth year-on-year.

Geographical revenue split

Revenue predominantly from India; distribution of imported brands involves multiple foreign countries.

Whats driving growth

Strong domestic demand for aesthetic solutions, product innovation, and expansion of own brand portfolio.

Our future plans

IPO planned to raise capital for working capital and general corporate purposes; expanding product pipeline.

Our people and values

Leadership with extensive industry experience fostering innovation and growth; compliance with workplace and ESG norms.

Key challenges ahead

Market competition, regulatory approvals, and dependency on import channels pose challenges.

Interesting facts

Transformed from private to public company; boasts diversified product brands launched between 2016-2024.

Risks and strategy

Mitigating import risks by strengthening own brands; maintaining regulatory compliance; pursuing B2B client relationships.

Market Footprint

Top Clients

Top Clients

B2B focus servicing dermatologists, plastic surgeons, and aesthetic physicians across India.

Top Products

Top Products

Own brands like Tubelite, Balback, Lytec, Etrelume, Swyada, Exoluxe; imported aesthetic devices and consumables.

StockkASK provides smart, AI-powered insights to support analysis. AI can make mistakes; verify independently before investing.Terms & Conditions